Consumer health product company LiveSpo Global secures $8.8 million investment
16:42 | 12/07/2021 Print Article
LiveSpo Global, an innovative consumer health product company, has recently wrapped up a $8.8 million investment from Mekong Capital's Mekong Enterprise Fund IV.
|LiveSpo Global is the fourth company to receive investment from Mekong Enterprise Fund IV |
LiveSpo Global is the fourth investee company announced by Mekong Enterprise Fund IV, including chocolate crafter Marou Chocolate Company, water purifiers manufacturer and distributor Mutosi Group, and cosmetics retailer HSV Group.
LiveSpo Global produces spore-based multi-strain probiotics in liquid form and high concentration using its own SporesProbiotics Technology.
Probiotics are made of health-promoting live bacteria and/or yeasts that naturally live in the human body. The most common and convenient forms of probiotic products are powders and capsules. These products require a long time for the helpful bacteria to be absorbed while most probiotics cannot survive in the acidic gastric environment of the stomach before reaching and improving the intestinal system.
LiveSpo’s Spores Probiotics Technology can formulate spore-based probiotics in liquid form for faster absorption along with producing a combination of concentrated multi-strain probiotics which can enhance the treatment of intestinal diseases, especially for the colon.
In addition, LiveSpo’s Spores Probiotics Technology can be applied on an industrial scale, enabling the company to expand its business not only in the domestic market but also exporting to more than 20 countries in the world.
LiveSpo Global, formerly known as ANABIO R&D, launched its first commercial spore-based probiotics in water form in 2013 and began exporting in 2014. The company has exported products to more than 20 countries.
LiveSpo Global’s domestic revenue comes from the pharmacy channel and online orders through the company’s website. As for export, they conduct online sales to the US and Europe via Amazon.com.